Paul Pavlidis
Overview
Explore the profile of Paul Pavlidis including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
138
Citations
6312
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kim J, Pavlidis P, Ciernia A
eNeuro
. 2024 Jul;
11(7).
PMID: 39029952
As rapid responders to their environments, microglia engage in functions that are mirrored by their cellular morphology. Microglia are classically thought to exhibit a ramified morphology under homeostatic conditions which...
2.
Morin A, Chu C, Chu C, Pavlidis P
bioRxiv
. 2024 Apr;
PMID: 38559016
The proliferation of single cell transcriptomics has potentiated our ability to unveil patterns that reflect dynamic cellular processes such as the regulation of gene transcription. In this study, we leverage...
3.
Colijn M, Carrion P, Poirier-Morency G, Rogic S, Torres I, Menon M, et al.
Prog Neuropsychopharmacol Biol Psychiatry
. 2023 Nov;
129:110888.
PMID: 37918557
Objective: SETD1A encodes a histone methyltransferase involved in various cell cycle regulatory processes. Loss-of-function SETD1A variants have been associated with numerous neurodevelopmental phenotypes, including intellectual disability and schizophrenia. While the...
4.
Harding R, Bermudez P, Bernier A, Beauvais M, Bellec P, Hill S, et al.
PLoS Comput Biol
. 2023 Jul;
19(7):e1011230.
PMID: 37498959
The Canadian Open Neuroscience Platform (CONP) takes a multifaceted approach to enabling open neuroscience, aiming to make research, data, and tools accessible to everyone, with the ultimate objective of accelerating...
5.
Nuechterlein A, Rotenberg A, LeDue J, Pavlidis P, Illes J
J Law Biosci
. 2023 Jul;
10(2):lsad016.
PMID: 37484885
The open science (OS) movement has garnered increasing support in academia alongside continued financial and reputational incentives to obtain intellectual property (IP) protections over research outputs. Here, we explore stakeholder...
6.
Morin A, Chu E, Sharma A, Adrian-Hamazaki A, Pavlidis P
Genome Res
. 2023 Jun;
33(5):763-778.
PMID: 37308292
Mapping the gene targets of chromatin-associated transcription regulators (TRs) is a major goal of genomics research. ChIP-seq of TRs and experiments that perturb a TR and measure the differential abundance...
7.
Novakovsky G, Sasaki S, Fornes O, Omur M, Huang H, Bayly C, et al.
Stem Cell Reports
. 2023 Feb;
18(3):765-781.
PMID: 36801003
Improving methods for human embryonic stem cell differentiation represents a challenge in modern regenerative medicine research. Using drug repurposing approaches, we discover small molecules that regulate the formation of definitive...
8.
Harnish J, Li L, Rogic S, Poirier-Morency G, Kim S, Boycott K, et al.
Hum Mutat
. 2022 Feb;
43(6):743-759.
PMID: 35224820
Next-generation sequencing is a prevalent diagnostic tool for undiagnosed diseases and has played a significant role in rare disease gene discovery. Although this technology resolves some cases, others are given...
9.
Chu E, Morin A, Chang T, Nguyen T, Tsai Y, Sharma A, et al.
PLoS Comput Biol
. 2021 Oct;
17(10):e1009484.
PMID: 34665801
To facilitate the development of large-scale transcriptional regulatory networks (TRNs) that may enable in-silico analyses of disease mechanisms, a reliable catalogue of experimentally verified direct transcriptional regulatory interactions (DTRIs) is...
10.
Lim N, Pavlidis P
Sci Rep
. 2021 Sep;
11(1):17624.
PMID: 34475469
The Connectivity Map (CMap) is a popular resource designed for data-driven drug repositioning using a large transcriptomic compendium. However, evaluations of its performance are limited. We used two iterations of...